REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for patients with relapsed T-Cell lymphoma
Disease control OngoingThis study tests a combination of two drugs, pembrolizumab (an immunotherapy that helps the immune system attack cancer) and romidepsin (a drug that blocks enzymes cancer cells need to grow), in people with peripheral T-cell lymphoma that has come back or stopped responding to tr…
Matched conditions: REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Vitamin d boosts cancer survival in new trial
Disease control OngoingThis study looks at whether giving vitamin D supplements to cancer patients who have low vitamin D levels can improve their survival and delay the need for treatment. About 565 adults with certain types of lymphoma or leukemia are taking part. Researchers are comparing those who …
Matched conditions: REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Virus-Immunotherapy combo targets tough skin cancers
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't improved with standard care. First, patients receive a virus-based drug (talimogene laherparepvec) injected into tumors to help the immune system recognize and attack cancer …
Matched conditions: REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:47 UTC